The inflammatory response in sepsis.

Area of Science:

• Immunology
• Pathophysiology
• Critical Care Medicine

Background:

• Sepsis pathophysiology, including systemic inflammatory response syndrome (SIRS), multiorgan failure, and death, remains incompletely understood.
• SIRS development in sepsis is linked to redox balance disruption, though it can occur in non-infectious conditions.
• Sepsis involves hyperinflammation, impaired phagocyte innate immunity, immunosuppression, and complement activation, culminating in septic shock and mortality.

Purpose of the Study:

• To review recent insights into immune and phagocytic cell signaling pathways in sepsis and SIRS.
• To explore potential therapeutic interventions targeting these pathways to mitigate sepsis-induced lethality.

Main Methods:

• Literature review of recent findings on sepsis and SIRS pathophysiology.
• Analysis of signaling pathways in immune and phagocytic cells during sepsis.
• Discussion of potential therapeutic targets.

Main Results:

• Key signaling pathways underlying sepsis and SIRS have been identified.
• Understanding these pathways is crucial for developing novel therapeutic strategies.
• Targeting specific pathways may reverse or attenuate lethal aspects of sepsis.

Conclusions:

• Further research into immune cell signaling in sepsis is warranted.
• Targeting identified pathways holds promise for improving sepsis treatment outcomes.
• Interventions aimed at modulating these pathways could reduce sepsis-related mortality.